• Forget the IPO, Illumina is nearing a buyout of $1.9B liquid biopsy startup Grail - report

    12 days ago - By San Diego Biotechnology

    Grail, the $1.9 billion, Jeff Bezos-backed liquid biopsy startup, may not be going public after all.
    Wednesday morning, a week after the biotech filed for an IPO, Bloomberg reported that Illumina was closing in on a deal for the vaunted spinout. Grail......
    Read more ...